Stay updated on Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page.

Latest updates to the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page
- Check3 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe study record page now shows a 403 Forbidden error with a header and a Home button, replacing the detailed study content and location information. Users can no longer access the trial details from this page.SummaryDifference19%

- Check24 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0, indicating a new version of the page's revision metadata. The change pertains to internal versioning and does not alter the user-visible content of the study page.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page's revision metadata was updated. The previous Revision: v3.6.5 was removed and a new Revision: v3.6.6 was added.SummaryDifference0.0%

- Check45 days agoChange DetectedA new identifier '2014 ( U.S. NIH Grant/Contract )' was added to the study's external identifiers. It serves as supplementary reference information in the trial record.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision badge at the bottom of the study page updated from v3.6.4 to v3.6.5, indicating a small maintenance update to the page.SummaryDifference0.0%

Stay in the know with updates to Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page.